OHSU in the news

The controversial ketamine-like drug that Trump is pushing on veterans

The Guardian June 18, 2019
In a story about the U.S. Department of Veteran’s Affairs promoting the use of the antidepressant esketamine, Erick Turner, M.D., said “That’s like a parent saying, “Because I said so’” about the FDA’s approach to approve the drug’s use.

A prescription for change

Observer Magazine June 11, 2019
A feature story about the psychological science behind addiction references a recent publication by Sarah Feldstein-Ewing, Ph.D. and collaborators that states that “almost 20% of high school students had received an opioid prescription by their senior year.”

The ADHD Overview from ADDitude

ADDitude June 11, 2019
Comment from Joel Nigg, Ph.D., is included in ADDitude’s overview of attention-deficit/hyperactive disorder: “ADHD is not a breakdown of the brain in one spot. It’s a breakdown in the connectivity, the communication networks and an immaturity in these networks.”
See more stories